Search - tctmd.com

Displaying 41 - 60 of 141

Sort: Relevancy | Date

2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI

Podcast TCTMD Talking Points

Atrial Fibrillation and PCI

January 02, 2019

News Daily News

US and European DAPT Guidelines More Alike Than Different, Say Experts

Yael L. Maxwell

December 03, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Presentation TCT 2018

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Renato D. Lopes

September 24, 2018

Presentation TCT 2018

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Yongwhi Park

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS: First Report of the Results in ACS and Non-ACS Subgroups

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Pascal Vranckx

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys

September 24, 2018

Presentation TCT 2018

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park

September 23, 2018

Presentation TCT 2018

De-Escalation of DAPT After DES Placement: Is There a Role for Personalized Treatment?

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Dániel Aradi

September 23, 2018

Presentation TCT 2018

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Patrick W. Serruys

September 23, 2018

Presentation TCT 2018

Managing Aspirin Allergy Before DES Placement

Presenter: Dominick J. Angiolillo, Elmir Omerovic, John A. Bittl

September 23, 2018

Presentation TCT 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Dominick J. Angiolillo

September 23, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Daily News

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

Todd Neale

August 17, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

Advertisement

Atrial Fibrillation and PCI

US and European DAPT Guidelines More Alike Than Different, Say Experts

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

GLOBAL LEADERS: First Report of the Results in ACS and Non-ACS Subgroups

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

De-Escalation of DAPT After DES Placement: Is There a Role for Personalized Treatment?

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

Managing Aspirin Allergy Before DES Placement

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

How Would I Treat This Patient?

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

New Review Probes Possibility of CVD Prevention Without Aspirin

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content